Serum Placental Growth Factor as a Marker of Cerebrovascular Disease Burden in Alzheimer’s Disease

• DOI: 10.3233/jad-230811
• Publication Date: 2024-01-09T17:07:07Z
• Authors: Liu-Yun Wu; Joyce R. Chong; Jenny P.C. Chong; Saima Hilal; Narayanaswamy Ven...; Boon Yeow Tan; Arthur Mark Richards; Christopher P. Chen; Mitchell K.P. Lai
• Keywords: 03 medical and health sciences; 0302 clinical medicine

Concomitant cerebrovascular diseases (CeVD) have been identified as an important determinant of Alzheimer's disease (AD) progression. Development robust blood-based biomarkers will provide critical tools to evaluate prognosis and potential interventional strategies for AD with CeVD.